Viewing nowBonsint 20 mg (Bonoprazan fumarate)
Vonoprazan Fumarate 26.72mg
Tablet · Prescription medication
Korea Takeda Pharmaceutical Co., Ltd.

MFDS item code 202503334 · Approved 2025.12.19
Treatment and maintenance of erosive reflux disease, treatment of gastric ulcers, and prevention of NSAID-induced ulcer recurrence
This medication is used for the treatment of gastric ulcers and erosive gastroesophageal reflux disease, and it is also used for maintenance therapy after treatment. Additionally, it helps prevent the recurrence of gastric or duodenal ulcers that may occur with the use of non-steroidal anti-inflammatory drugs (NSAIDs). With these effects, it effectively manages gastrointestinal-related diseases.
● Treatment of gastric ulcers Administer 20 mg of vonoprazan orally once daily to adults. Treatment is generally given for up to 8 weeks. ● Treatment of erosive gastroesophageal reflux disease and maintenance therapy after treatment Treatment: Administer 20 mg of vonoprazan orally once daily to adults. Treatment is generally given for up to 4 weeks. If the effect is insufficient, treatment may be continued for up to 8 weeks. Maintenance therapy: Administer 10 mg once daily. If the effect is insufficient, 20 mg may be administered once daily. ● Prevention of recurrence of gastric or duodenal ulcers during administration of nonsteroidal anti-inflammatory drugs (NSAIDs) Administer 10 mg of vonoprazan orally once daily to adults.
This medication should not be used in patients who are allergic to this drug or any of its components or have experienced hypersensitivity reactions. Patients currently taking certain antivirals, such as atazanavir, nelfinavir, or rilpivirine, should not use this medication concurrently. Patients with renal or liver issues, as well as the elderly, should exercise caution when using this drug. Common symptoms from taking this medication may include abdominal pain, constipation, diarrhea, nausea, and vomiting, and rare cases of allergic reactions or liver function abnormalities may occur. If liver function abnormalities are suspected, discontinue use immediately and consult a doctor. For patients with recurrent gastroesophageal reflux disease, it is recommended to only use this medication, and reduce or discontinue the dosage when symptoms improve. This drug may be used to prevent the recurrence of gastric ulcers in patients taking NSAIDs for a prolonged period, but previous history of gastric ulcer must be verified. Long-term use may lead to the formation of gastric polyps, so regular examinations are necessary. This medication may mask symptoms of gastric cancer, so malignancy must be confirmed before use. Caution is also advised in elderly patients or with prolonged high-dose administration due to increased risk of osteoporosis and fractures. This drug alters gastric acidity, potentially affecting the absorption of certain medications; thus, effects may decrease or side effects may increase with some drug combinations. Pregnant or breastfeeding women should consult a doctor before taking this medication, and it's preferable to avoid use unless necessary. Safety in children has not been established; use in children should be cautious. When taking the medication, be careful not to swallow the tablet packaging and ensure to take out only the tablet from the packaging to prevent esophageal damage from the packaging.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture. It is important to maintain a temperature between 1°C and 30°C for storage. This helps to preserve the drug's effectiveness.
Pale red oval film-coated tablet
100 tablets/box [10 tablets/PTP × 10]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowVonoprazan Fumarate 26.72mg
Tablet · Prescription medication
Korea Takeda Pharmaceutical Co., Ltd.
Vonoprazan Fumarate 26.72mg
Tablet · Prescription medication
Takeda Korea Co., Ltd.
Vonoprazan Fumarate 13.36mg
Tablet · Prescription medication
Takeda Korea Pharmaceutical Co., Ltd.
Vonoprazan Fumarate 26.72mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.
Vonoprazan Fumarate 13.36mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Vonoprazan Fumarate 13.36mg
Tablet · Prescription medication
Takeda Pharmaceuticals Korea Co., Ltd.
Vonoprazan Fumarate 26.72mg
Tablet · Prescription medication
White Life Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.